The Prime Value Imputation Fund outperformed the S&P/ASX300 Accumulation Index by 0.5% in March, gaining +8.6% during the month.
During the month the Fund was overweight in industrial stocks and underweight in health care and telecom sectors, which contributed positively to the overall result. Individual stock positions that performed strongly included Monadelphous, Westpac and NAB. Telstra and Caltex were negative influences. The Fund's ongoing cash position held back performance in a month of strong market rallies.
Prime Value's Growth Fund also performed well in March, up +6.1%. The Fund suffered from an underweight position in financial stocks, as well as the Fund's cash holding.
